Skip to main content

Treatment Signs Ocean Medical Agreement For The AI Driven Doctors Office

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, Dec. 16, 2021 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment or the (“Company”) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers globally with easy, AI-driven solutions.

Today Treatment announces the first sale of its Treatment Primary Care Module, powering the next generation of AI-assisted healthcare. Using medically built artificial intelligence, the Treatment Primary Care Module will improve all aspects of the patient / doctor experience in the medical clinic setting. Powered by the rapidly expanding Global Library of Medicine and micro service AI technologies, this new solution integrates seamlessly with the medical clinics’ EMR system. This dramatically improves the patient workflow, while aiding busy medical professionals with their clinical practice.

Instead of doctors spending valuable patient time at the keyboard, entering symptoms and other critical medical information, the Treatment AI system “pre-interviews” the patient in the comfort of their home, then builds an extremely accurate list of personalized symptoms, risk factors and possible diagnoses just as the doctor would have done. Then when the patient is seen, either in the clinic or over a video link, the doctor can simply review the AI-curated evidence and make final diagnosis and treatment recommendations more accurately and quickly.

“This is transformational,” said Dr. Rob Scott, clinic owner. “The earlier pilot proved to us that this is going to be what all providers will need to stay competitive. Since the Treatment AI system interviews the patient first and writes a report in the format I would have anyway, it saves me time, allows more productive discussions with the patient, and on many occasions, reminds our busy practitioners about diagnoses they might not have considered. This is truly the next generation of health care, and we are proud to be leading the way in partnership with Treatment.”

“This agreement ensures Ocean Medical patients and providers will be working in the doctor’s office of the future and they too will become a beacon of vision for medical clinics around the globe,” says William Sigsbee, Chief Commercial Officer, Treatment.com. “It has been a pleasure working with this visionary team and they will become a key partner for Treatment, as we release many other new products in coming months and years.”

“I am extremely proud to partner with Dr. Rob Scott and his forward-looking providers to begin a new chapter in AI-enhanced health care,” said Mr. John Fraser, CEO of Treatment. “My amazing global team of doctors and AI experts has been successful in helping providers automate the most complex part of healthcare, diagnosing and recommending treatments when we get sick – and this is just the first step in a long and exciting journey.”

About Treatment.com

Treatment.com is a disruptive healthcare technology company that is harnessing the power of AI to help global citizens improve their health through personalized recommendations and insights. Based in Vancouver with a US subsidiary, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment Mobile is a soon to be released intelligent digital health assistant which will empower people to take control of their health through an innovative mobile app, powered by Treatment’s exclusive AI engine.

For more investor information on Treatment.com please visit https://treatment.com/investors/.

Forward Looking Statement

This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment’s expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

For more information:

Investor Contact: investors@treatment.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.